Diagnosis and treatment of gastric neuroendocrine tumours

Wiener Klinische Wochenschrift

Volumn 119, Issue 19-20, 2007, Pages 570-572

  Plöckinger, Ursula ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Gastric neuroendocrine tumors; Hypergastrinemia; MEN1

Indexed keywords

CANCER INCIDENCE; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; RARE DISEASE; SEX RATIO; SHORT SURVEY; STOMACH TUMOR; TUMOR CLASSIFICATION; TUMOR GROWTH; WORLD HEALTH ORGANIZATION;

BIOPSY; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; DUODENAL NEOPLASMS; ENTEROCHROMAFFIN-LIKE CELLS; GASTRIC MUCOSA; GASTRINOMA; GASTRINS; GASTRITIS, ATROPHIC; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 34548012661     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-007-0879-z     Document Type: Short Survey

References (16)

1. Plockinger U, Rindi G, Arnold R, Eriksson B, Krenning EP, de Herder WW, et al (2004) Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 80: 394-424
2. Rindi G, Capella C, Solcia E (2000) Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract. Q J Nucl Med 44: 13-21
3. Solcia E, Rindi G, Larosa S, Capella C (2000) Morphological, molecular, and prognostic aspects of gastric endocrine tumors. Microsc Res Tech 48: 339-348
4. Solcia E, Rindi G, Buffa R, Fiocca R, Capella C (2000) Gastric endocrine cells: types, function and growth. Regul Pept 93: 31-35
5. Rindi G, Kloppel G (2004) Endocrine tumors of the gut and pancreas tumor biology and classification. Neuroendocrinology 80 [Suppl 1]: 12-15
6. Kloppel G, Perren A, Heitz PU (2004) The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann NY Acad Sci 1014: 13-27
7. Rindi G, Paolotti D, Fiocca R, Wiedenmann B, Henry JP, Solcia E (2000) Vesicular monoamine transporter 2 as a marker of gastric enterochromaffin-like cell tumors. Virchows Arch 436: 217-223
8. Borch K, Ahren B, Ahlman H, Falkmer S, Granerus G, Grimelius L (2005) Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg 242: 64-73
9. Xie SD, Wang LB, Song XY, Pan T (2004) Minute gastric carcinoid tumor with regional lymph node metastasis: a case report and review of literature. World J Gastroenterol 10: 2461-2463
10. Fykse V, Sandvik AK, Qvigstad G, Falkmer SE, Syversen U, Waldum HL (2004) Treatment of ECL cell carcinoids with octreotide LAR. Scand J Gastroenterol 39: 621-628
11. Delle Fave G, Capurso G, Annibale B, Panzuto F (2004) Gastric neuroendocrine tumors. Neuroendocrinology 80 [Suppl 1]: 16-19
12. Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD (2005) Current status of gastrointestinal carcinoids. Gastroenterology 128: 1717-1751
13. Norton JA, Melcher ML, Gibril F, Jensen RT (2004) Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment. Surgery 136: 1267-1274
14. Mulkeen A, Cha C (2005) Gastric carcinoid. Curr Opin Oncol 17: 1-6
15. Thomas RM, Baybick JH, Elsayed AM, Sobin LH (1994) Gastric carcinoids. An immunohistochemical and clinicopathologic study of 104 patients. Cancer 73: 2053-2058
16. Rindi G, Azzoni C, La Rosa S, Klersy C, Paolotti D, Rappel S, et al (1999) ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 116: 532-542